Sarcoidosis en un atleta de alto rendimiento con patrón recidivante en “árbol en gemación”

Ricardo Durán Acuña; Camila Durán Barrera; Carolina Araque Parra; Rafael Parra Medina; José Fernando Polo Nieto

Sarcoidosis with a recurrent “tree-in-bud” pattern in a high-performance athlete

Sarcoidosis en un atleta de alto rendimiento con patrón recidivante en “árbol en gemación”

Published 2016-03-01

Open | Download

PDF (Spanish) FLIP

Issue

Vol. 25 No. 1 (2016): Janaury - March

Section

Case Reports

How to Cite

Durán Acuña, R., Durán Barrera, C., Araque Parra, C., Parra Medina, R., & Polo Nieto, J. F. (2016). Sarcoidosis with a recurrent “tree-in-bud” pattern in a high-performance athlete. Journal of Medicine and Surgery Repertoire, 25(1), 40-45. https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/76

DOI

license

Ricardo Durán Acuña

Camila Durán Barrera

Carolina Araque Parra

Rafael Parra Medina

José Fernando Polo Nieto

Show authors biography

Sarcoidosis

Lungs

Granulomas

Sarcoidosis is a chronic systemic granulomatous disorder of unknown origin. It predominantly affects the lungs, but it can affect any organ. Sarcoidosis is a diagnosis of exclusion. A strict clinical, radiological and histopathological correlation is required for diagnosis and adequate treatment and follow-up. Herein we present the case of a young high-performance male athlete with an unusual radiological finding.

Article visits 348 | PDF visits 446

Downloads

Download data is not yet available.

1. Baughman RP, Culver DA. Sarcoidosis. Clin Chest Med. 2015;36.

2. Hamzeh N. Sarcoidosis. Med Clin North Am. 2011;95:1223–34.

3. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160:736-55.

4. Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. AM J Respir Crit Care Med. 2001;164:1885–9.

5. Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J. 2008;31:372–9.

6. Sharma OP. Sarcoidosis around the world. Clin Chest Med. 2008;29:357–63.

7. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234–41.

8. Pacheco M, Ojeda P, Chaparro P, Garay M. Lesión traqueal no neoplásica. Sarcoidosis. Descripción de un caso y revisión de la literatura. Rev. Colomb. Neumol. 2012;23:130–5.

9. Morgenthau AS, Iannuzzi MC. Recent advances in sarcoidosis. Chest. 2011;139:174–82.

10. Edelsten C, Pearson A, Joynes E, Stanford MR, Graham EM. The ocular and systemic prognosis of patients presenting with sarcoid uveitis. Eye (Lond). 1999;13 Pt 6:748–53.

11. Baughman RP, Lower EE, Kaufman AH. Ocular sarcoidosis. Semin Respir Crit Care Med. 2010;31:452–62.

12. Papadia M, Herbort CP, Mochizuki M. Diagnosis of ocular sarcoidosis. Ocul Immunol Inflamm. 2010;18:432–41.

13. Design of a case control etiologic study of sarcoidosis, (ACCESS). ACCESS Research Group. J Clin Epidemiol. 1999;52:1173–86.

14. Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324–30.

15. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep. 2010;59(RR-5): 1–25.

16. Gupta D, Agarwal R, Aggarwal AN, Jindal SK. Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis. Eur Respir J. 2007;30:508–16.

17. Kendrick CG, Brown RA, Reina R, Ford BP, Reed RJ, Nesbitt LT Jr. Cutaneous sarcoidosis presenting as leonine facies. Cutis. 2004;73:57–62.

18. Ijnen PA, Voorter CE, Nelemans PJ, Verschakelen JA, Bekers O, Drent M. Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression? Hum Immunol. 2011;72:342–7.

19. Spagnolo P, Sato H, Grutters JC, Renzoni EA, Marshall SE, Ruven HJ, et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue antigens. 2007;70:219–27.

20. Cozier YC, Berman JS, Palmer JR, Boggs DA, Serlin DM, Rosenberg L. Sarcoidosis in black women in the United States: data from the Black Women’s Health Study. Chest. 2011;139:144–50.

21. Iannuzzi M. Sarcoidosis. En: Goldman L, Schafer AI, editores. Cecil y Goldman Tratado de medicina interna. España: Elsevier; 2013. p. 586–90.

22. Hidalgo A. Radiología de las infecciones fúngicas invasoras del aparato respiratorio. Sección de radiología torácica, Servicio de radiodiagnóstico, Hospital de la Santa Creu i Sant Pau. Rev Iberoam Micol Barcelona. 2007;24:14–8.